Will Mounjaro be FDA approved for weight loss by Jan 31st, 2024?
Basic
5
Ṁ984resolved Nov 10
Resolved
YES1D
1W
1M
ALL
The drug Mounjaro has been FDA approved for diabetes management for several years. The FDA has fast tracked it for weight loss approval. Will it be approved for this usage by the end of January?
This question is managed and resolved by Manifold.
Get
1,000and
3.00
1,0003.00Sort by:
@NathanielMonson yes, I missed it until today too. This is great news for everyone except the makers of ozempic.
Related questions
Related questions
Will Pfizer announce a weight loss drug competing with Ozempic and Wygovy before 12/31/2024?
35% chance
Will a clinical trial reporting weight-loss benefits of a GLP-1 agonist be published in a major medical journal in 2024?
78% chance
Will AOH1996 be FDA approved before 2040?
44% chance
[ACX 2024] Will the FDA or EMA withdraw approval of semaglutide for the treatment of obesity or diabetes in 2024?
1% chance
Will the FDA approve a drug to prevent migraine headaches by 2025?
66% chance
Will Retatrutide (new obesity drug) be FDA approved by the end of 2025?
36% chance
Will Retatrutide (new obesity drug) be FDA approved by the end of 2024?
4% chance
Will Ozempic be FDA approved for use in type 1 diabetes patients by end of 2024?
11% chance
Will Donald Trump ever take a GLP-1 agonist (eg Ozempic, Mounjaro, Wegovy, Zepbound, etc) for weight loss
65% chance
Affordable weight loss drugs before 2030?
76% chance